Cefiderocol Activity against Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex, Including Molecularly Characterized Clinical Isolates, Causing Infections in United States Hospitals (2020–2023)
Cefiderocol Activity against Carbapenem-Resistant <i>Acinetobacter baumannii-calcoaceticus</i> Complex, Including Molecularly Characterized Clinical Isolates, Causing Infections in United States Hospitals (2020–2023). Lead author: Rodrigo E. Mendes, IDWeek 2024, October 16-19, Los Angeles, CA, USA
Poster #P1362
